NDC 17856-0353-2 - Pharbetol Regular strength
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 17856-0353
- Requested NDC
- 17856-0353-2
- Package NDCs from labels
- 17856-0353-2, 17856-0353-1, 17856-0353-4, 17856-0353-3
- Manufacturer
- ATLANTIC BIOLOGICALS CORP.
- Effective date
- 2025-06-05
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| PHARBEST IBUPROFEN Drug Facts | ATLANTIC BIOLOGICALS CORP. | 2025-06-05 | HUMAN OTC DRUG LABEL |
| Pharbetol Regular strength - ATLANTIC BIOLOGICALS CORP. | UNIT DOSE SOLUTIONS | ATLANTIC BIOLOGICALS CORP. | UNIT DOSE SOLUTIONS | 2024-04-30 | HUMAN OTC DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 17856-0353-1 | 2024-06-26 | C162847 | 48780-1 | 1030e365-250f-111a-e063-dadaa90a10e2 | PHARBEST IBUPROFEN Drug Facts |
| 17856-0353-1 | 2024-01-30 | C162847 | 48780-1 | 1030e365-250f-111a-e063-dadaa90a10e2 | PHARBEST IBUPROFEN Drug Facts |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 17856-0353-1 | PharbetolRegular strength | 100 in 1 BOX, UNIT-DOSE | TABLET | 100 | 3 | |
| 17856-0353-2 | PharbetolRegular strength | 1 in 1 POUCH | TABLET | 1 | 3 | |
| 17856-0353-4 | PharbetolRegular strength | 24 in 1 BOTTLE | TABLET | 24 | 3 | |
| 17856-0353-3 | PharbetolRegular strength | 28 in 1 BOTTLE | TABLET | 28 | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 17856-0353 | PHARBETOL REGULAR STRENGTH (ACETAMINOPHEN) TABLET [ATLANTIC BIOLOGICALS CORP.] | 2 | Current NDC, Legacy NDC, 3 package rows | 20240627_05a91d24-b498-4ba2-a275-68b871cf62d2.zip |
| 17856-0353 | PHARBETOL REGULAR STRENGTH (ACETAMINOPHEN) TABLET [ATLANTIC BIOLOGICALS CORP.] | 1 | Current NDC, Legacy NDC, 1 package rows | 20240508_bd26081c-e81e-42e8-b3da-2813863a51df.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| migraine relief | ACETAMINOPHEN, ASPIRIN, CAFFEINE | Walgreen Company | 5dcc2b01-6556-46bc-a451-f09dd0bd1eed | 2025-09-04 | Warnings | 362O9ITL9D |
| Combogesic | ACETAMINOPHEN AND IBUPROFEN | Preferred Pharmaceuticals Inc. | cd03b658-dba1-4a12-8f6f-ab00da499c05 | 2025-09-04 | Boxed warning, Warnings, Adverse reactions | 362O9ITL9D |
| topcare day time cold and flu | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, PHENYLEPHRINE HYDROCHLORIDE | Topco Associates LLC | 256d96f0-67bf-42d2-85ef-f49625c5910f | 2025-09-02 | Warnings | 362O9ITL9D |
| topcare nite time cold and flu | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE, PHENYLEPHRINE HYDROCHLORIDE | Topco Associates LLC | ef574f18-e28d-46bb-87fd-2f3b4df6dc68 | 2025-09-02 | Warnings | 362O9ITL9D |
| Cold Multi-Symptom | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, PHENYLEPHRINE HCL | Kroger Company | f4429475-47f9-451a-bfcc-24b5ef333923 | 2025-09-02 | Warnings | 362O9ITL9D |
| Extra Strength Acetaminophen PM | ACETAMINOPHEN, DIPHENHYDRAMINE | BJWC (Berkley & Jensen / BJ's) | 2f473f1f-7cf3-2af5-e063-6394a90aaa17 | 2025-09-01 | Warnings | M013 362O9ITL9D |
| foster and thrive rapid release pain relief | ACETAMINOPHEN | Strategic Sourcing Services LLC | d2130173-b107-4ae6-a1f7-6db467da3820 | 2025-08-30 | Warnings | M013 362O9ITL9D |
| Acetaminophen | ACETAMINOPHEN | Precision Dose, Inc. | e1d4f562-433c-4344-9b77-1a7c731d1be5 | 2025-08-29 | Warnings | M013 362O9ITL9D |
| dg health night time cold and flu relief | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, DOXYLAMINE SUCCINATE | Dolgencorp Inc | dc8cc7a3-60a9-42f0-babd-d3c7d0276dd1 | 2025-08-29 | Warnings | 362O9ITL9D |
| ENDOCET | OXYCODONE AND ACETAMINOPHEN | Redpharm Drug | 3251c37b-8e31-a613-e063-6294a90ae982 | 2025-08-28 | Boxed warning, Warnings, Adverse reactions | 362O9ITL9D |
| Equaline migraine formula | ACETAMINOPHEN, ASPIRIN, CAFFEINE | United Natural Foods, Inc. dba UNFI | 28ab87e5-6b7d-4737-95e8-4f842ecd9408 | 2025-08-28 | Warnings | 362O9ITL9D |
| Sinus Relief Pressure and Pain | ACETAMINOPHEN, GUAIFENESIN, PHENYLEPHRINE HCL | Kroger Company | 98de5cff-3ff5-49b0-bef9-5b9ebb86491e | 2025-08-27 | Warnings | 362O9ITL9D |
| Nighttime SEVERE | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE, PHENYLEPHRINE HYDROCHLORIDE | H E B | 0a178114-0748-4a92-9b60-a7a0a8b72287 | 2025-08-26 | Warnings | 362O9ITL9D |
| good neighbor pharmacy migraine relief | ACETAMINOPHEN, ASPIRIN, CAFFEINE | Amerisource Bergen | 201f101a-3b53-4349-896c-6b86cdd9b831 | 2025-08-26 | Warnings | 362O9ITL9D |
| Hydrocodone Bitartrate and Acetaminophen | HYDROCODONE BITARTRATE AND ACETAMINOPHEN | Camber Pharmaceuticals, Inc. | 4d5bfd3a-3793-4d24-aedd-c04fa34ea736 | 2025-08-26 | Boxed warning, Warnings, Adverse reactions | 362O9ITL9D |
| pain relief | ACETAMINOPHEN | Safeway | 0e0a73f9-8c18-41fd-812e-8be20287e77a | 2025-08-26 | Warnings | M013 362O9ITL9D |
| good sense pain relief arthritis pain | ACETAMINOPHEN | Bryant Ranch Prepack | 7b0b07f6-242a-4e1a-ab39-84f0334d4716 | 2025-08-26 | Warnings | 362O9ITL9D |
| Aspirin Low Dose Safety Coated | ASPIRIN | BJWC (Berkley & Jensen / BJ's) | 577035a5-88ab-431c-8598-7a19dd633fe9 | 2025-08-26 | Warnings | M013 |
| CAREONE DUAL ACTION | ACETAMINOPHEN, IBUPROFEN | Retail Business Services, LLC | 76302cb3-0371-49ce-85d8-5f3785c370b0 | 2025-08-25 | Warnings | 362O9ITL9D |
| Topcare Pain Relief | ACETAMINOPHEN | Sixarp, LLC | 2e20be17-2b6c-1a07-e063-6394a90acdd3 | 2025-08-25 | Warnings | M013 362O9ITL9D |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.